Johnson & Johnson Offers $5.5bn to Settle Baby Powder Lawsuits

Johnson & Johnson (J&J) has put forward a proposal of up to $5.5bn (£4.14bn) to resolve tens of thousands of legal cases in the United States. These cases allege that the company's baby powder and other products containing talcum led to ovarian cancer. The proposed resolution aims to conclude a protracted legal dispute that has impacted the New Jersey-based healthcare firm for several years.

J&J has consistently denied that its talc-based products are responsible for causing cancer. The company has also altered the formulation of its widely used baby powder. Erik Haas, the firm's vice president of litigation, stated on Monday that the allegations are unfounded and that J&J is willing to settle to bring the matter to a close. The company is confident it would have prevailed in further legal proceedings, as it has in most cases heard to date, according to Haas.

Scope of the Proposed Settlement

Read Next in Barnet Press2 min read

Arsenal Pursue Bruno Guimaraes Amid Newcastle Rejections

Newcastle United has rejected multiple offers from Arsenal for midfielder Bruno Guimaraes, who is reportedly open to a move.

The proposed settlement is intended to cover approximately 76,000 cases, representing the majority of outstanding claims related to talc. J&J indicated it would offer up to $3bn in the coming year, with no further payments scheduled before 2028. For the proposal to be finalised, it requires acceptance from legal representatives of 95% of the ovarian cancer claims filed in both state and federal courts, as reported by the BBC.

Haas added that this proposed resolution would allow the company to move past this issue and concentrate on its objective of developing treatments and devices that save lives. J&J's former consumer health division, Kenvue, which was spun off in 2022, holds responsibility for Johnson's baby powder sales outside of North America. Lawsuits concerning J&J's talc-based baby powder date back to 2009.

Background on Talc and Allegations

Related Borough Coverage3 min read

Burnham launches £31bn submarine programme phase

New contracts worth £8.4bn to support 18,000 extra jobs in nuclear defence by 2030.

Talc, a mineral composed of magnesium, silicon, oxygen, and hydrogen, is known for its smooth texture and is commonly used in baby powder. Lawsuits have been filed by consumers and their families who assert that J&J's talc products caused cancer due to potential contamination with asbestos. Asbestos is a material known to cause cancer and is often found in geological seams near where talc is mined. Johnson & Johnson has repeatedly refuted these claims, stating that studies show talc is safe, free from asbestos, and does not cause cancer.

In 2022, Johnson & Johnson announced its decision to cease the production and sale of its talc-based baby powder worldwide. This announcement followed the company's discontinuation of sales for the product in the United States more than two years prior. At the time, J&J stated that this transition to an all cornstarch-based baby powder portfolio was a commercial decision resulting from a global portfolio assessment.